AS Latvijas Juras medicinas centrs (UOM) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.82x

AS Latvijas Juras medicinas centrs (UOM) has a Cash Flow Reinvestment Rate of 1.82x as of September 2025, reinvesting €861.78K (capex €430.89K plus investments €-430.89K) from operating cash flow of €474.45K. See AS Latvijas Juras medicinas centrs free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.82x
(Capex + Investments) / Operating CF

Total Reinvested

€861.78K
Capex + Investments

Operating Cash Flow

€474.45K
EUR

Capital Expenditures

€430.89K
EUR

AS Latvijas Juras medicinas centrs Cash Flow Reinvestment Rate (2015–2024)

Historical reinvestment intensity for AS Latvijas Juras medicinas centrs across 10 annual periods. For the full cash flow conversion analysis, see AS Latvijas Juras medicinas centrs cash flow conversion.

Annual Cash Flow Reinvestment Rate for AS Latvijas Juras medicinas centrs (2015–2024)

Year-by-year capital reinvestment analysis for AS Latvijas Juras medicinas centrs. See AS Latvijas Juras medicinas centrs financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 1.44x €872.42K €605.02K €436.21K ▼ -44.4%
2023 2.59x €4.96 Million €1.91 Million €2.48 Million ▲ +92.4%
2022 1.35x €1.47 Million €1.09 Million €629.72K ▼ -74.6%
2021 5.31x €2.22 Million €418.24K €1.11 Million ▲ +277.5%
2020 1.41x €1.03 Million €732.71K €515.12K ▲ +52.9%
2019 0.92x €379.64K €412.86K €190.16K ▲ +112.3%
2018 0.43x €259.66K €599.57K €86.45K ▼ -83.1%
2017 2.57x €1.23 Million €478.41K €605.51K ▼ -35.8%
2016 4.00x €1.67 Million €418.49K €860.13K ▲ +457.5%
2015 0.72x €260.06K €362.36K €260.06K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow